← Leaderboards
Bill Basinger
Countervail Corporation
$3,028,489
Attributed
$3,028,489
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $981.7K · FY2010–18$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,028,489 · 2
By mechanism
R44$2,803,264 · 1
R43$225,225 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelAnimal RuleAnimalsAnimal Welfare ActAntidotesApplications GrantsAtropineBaseBrainBrain TissueBromidesBusinessesCarboxylesteraseCarboxylic Ester HydrolasesCause Of DeathCaviaCharacteristicsCollectionCommercializationDepartment Of DefenseDoseDrug CandidateDrug KineticsAcetylcholinesterase
Grant awards (5)
Rapid Baseline Free Organophosphate Exposure Diagnostic Test$225,225
R43 · FY2018 · NS · contact PI
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$630,123
R44 · FY2015 · NS · contact PI
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$844,970
R44 · FY2014 · NS · contact PI
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$981,654
R44 · FY2011 · NS · contact PI
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$346,517
R44 · FY2010 · NS · contact PI